Patent Assignment
Reel/Frame 057751/0620
Assignment of Assignor's Interest
Recorded: 2021-10-11
Pages: 4
Assignee
CHEMOCENTRYX, INC.
835 INDUSTRIAL ROAD, SUITE 600, SAN CARLOS, CALIFORNIA, 94070
Covered Properties
(2)
Combination therapy using a Chemokine Receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor
Application:
62/950,780 →
Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a PD-1 and/or PD-L1 Inhibitor
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignee Change of Address
Jun 27, 2023
From: CHEMOCENTRYX, INC.
To: CHEMOCENTRYX, INC.
Reel/Frame 064144/0596 →
Confirmatory License
Oct 2, 2023
From: UNIVERSITY OF FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065091/0289 →